selected publications
-
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver international : official journal of the International Association for the Study of the Liver.
2023
Academic Article
GET IT
Times cited: 2 -
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2023
Academic Article
GET IT
Times cited: 9 - Fatalistic cancer beliefs and self-reported cancer screening behaviors among diverse urban residents. Journal of behavioral medicine. 2022 Academic Article GET IT
-
A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma.
Current oncology (Toronto, Ont.).
2022
Review
GET IT
Times cited: 2 -
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.
Journal for immunotherapy of cancer.
2022
Academic Article
GET IT
Times cited: 5 -
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Hepatology communications.
2022
Academic Article
GET IT
Times cited: 2 -
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
Cancers.
2021
Academic Article
GET IT
Times cited: 27 -
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
Liver cancer.
2021
Academic Article
GET IT
Times cited: 19 -
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
European journal of cancer (Oxford, England : 1990).
2021
Academic Article
GET IT
Times cited: 25 -
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment.
American journal of clinical oncology.
2021
Academic Article
GET IT
Times cited: 13 -
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
Therapeutic advances in medical oncology.
2021
Academic Article
GET IT
Times cited: 96 -
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 17 -
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies.
Journal of clinical medicine.
2020
Review
GET IT
Times cited: 8 -
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 29 -
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.
Cancers.
2020
Academic Article
GET IT
Times cited: 47 -
Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer.
Expert opinion on biological therapy.
2019
Review
GET IT
Times cited: 17 -
Optimizing Therapies in the Perioperative Management of Gastric Cancer.
Current treatment options in oncology.
2019
Review
GET IT
Times cited: 12 - Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2019 Review GET IT
-
Prognostic Utility of Tumor-Infiltrating Lymphocytes in Noncolorectal Gastrointestinal Malignancies.
International journal of surgical pathology.
2018
Academic Article
GET IT
Times cited: 2 -
T Lymphocytes and Autoimmunity.
International review of cell and molecular biology.
2018
Review
GET IT
Times cited: 65 -
Role of "Second Look" Lymph Node Search in Harvesting Optimal Number of Lymph Nodes for Staging of Colorectal Carcinoma.
Gastroenterology research and practice.
2018
Academic Article
GET IT
Times cited: 114 - Acute myeloid leukemia with translocation (1;21). Molecular biology reports. 2018 Review GET IT
-
Autoimmune Hepatitis: A Risk Factor for Cholangiocarcinoma.
2017
GET IT
Times cited: 2 -
Benign Multicystic Peritoneal Mesothelioma: A Rare Condition in an Uncommon Gender.
2017
GET IT
Times cited: 30 -
Plasmacytomas and Plasma-Cell Leukemia.
2017
GET IT
Times cited: 1 -
Fever, rash and agranulocytosis.
2017
GET IT
Times cited: 1 -
Immunotherapy-associated autoimmune hemolytic anemia.
2017
GET IT
Times cited: 44 -
Nivolumab induced myxedema crisis.
2017
GET IT
Times cited: 32 - Composite Lymphoma: Opposite Ends of Spectrum Meet. 2017 GET IT
-
Sweet syndrome: a painful reality.
2016
GET IT
Times cited: 7 -
RUSH for G6PD!
2016
GET IT
Times cited: 1 - Circulating lymphoma cells of double-hit lymphoma. 2016 GET IT
- Sickle cell trait: not as benign as once thought. 2014 GET IT